Literature DB >> 10176777

Valuing morbidity: an integration of the willingness-to-pay and health-status index literatures.

F R Johnson1, E E Fries, H S Banzhaf.   

Abstract

Placing dollar values on human health has long been a controversial aspect of policy analysis and remains difficult given the relatively small number of morbidity-valuation studies available. By combining both the economic and health literature, this paper offers an alternative approach to morbidity valuation and provides estimates for a wide range of short-term health conditions.

Entities:  

Mesh:

Year:  1997        PMID: 10176777     DOI: 10.1016/s0167-6296(97)00012-x

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  4 in total

1.  The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.

Authors:  Grace Wu; Krista L Lanctôt; Nathan Herrmann; Shehnaz Moosa; Paul I Oh
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Methods for the meta-analysis of willingness-to-pay data: an overview.

Authors:  George Van Houtven
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

3.  Economic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollution.

Authors:  David M Stieb; Paul De Civita; F Reed Johnson; Matthew P Manary; Aslam H Anis; Robert C Beveridge; Stan Judek
Journal:  Environ Health       Date:  2002-12-18       Impact factor: 5.984

4.  Is the value of a life or life-year saved context specific? Further evidence from a discrete choice experiment.

Authors:  Duncan Mortimer; Leonie Segal
Journal:  Cost Eff Resour Alloc       Date:  2008-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.